Epic Experience provides an action-packed week of activities that will fuel the soul, provide an opportunity to make connections with other individuals who share similar stories and create a community that will last long after the camp has ended.
Participating in Clinical Trials: Common Myths and Questions to Consider
The annual “Light the Night” walk is a fundraising campaign sponsored by The Leukemia & Lymphoma Society (LLS). Its goal is to bring together families and communities to honor blood cancer survivors and those who have passed.
My favorite part of the job is learning the stories behind the cancer. I love connecting with my patients and their families during such a vulnerable time in their lives and becoming familiar with their world.
Here at the University of Colorado I’m very proud that our leukemia program has been a leading contributor to some of the most exciting recent clinical trials for AML and MDS.
Find information about Cancer Support Groups in Colorado.
Dr. Pollyea will utilize funding from this award to develop a program to systematically test leukemia stem-cell directed therapies.
Sign up for our patient focused digital newsletter, The Bloodline, which is published quarterly. The newsletter includes tips for patients, articles on self-care, a dietician approved recipe and information on what’s going on with our program.
A new program at the University of Colorado Cancer Center provides individual mentoring to patients and caregivers to provide additional support through the cancer journey. Meet Kaitlyn Cavanaugh, the Imerman Angels Program Ambassador for Colorado.
Join a group of moms training to run or walk a 10K or half marathon while raising money to help find a cure for blood cancers.
From her favorite part about her job to her favorite movie, our “Behind the Scrubs” interview with our new Post-Transplant Survivorship coordinator gives you a chance to get to know a little about Sarah Strozinski, RN, BSN, OCN and her role on our team.
Research tells us that when implementing any new goal for yourself, it is helpful to make your goal specific, obtainable, manageable, and relevant to you. You may be asking yourself “How do I go about making, and specifying, a goal for myself?”
In the featured article in the December issue of Nature Reviews Cancer, Dr. Graham describes the emerging field of TAM family kinases and their potential as therapeutic targets in leukemia and other forms of cancer.
Speaking at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Barcelona, Spain, Dr. Pollyea summarized the latest results for AG-120, an exciting new drug for the treatment of patients with advanced leukemia.
Israel has the highest BRCA+ prevalence of any nation. Rabinovitch will deliver lectures and collaborate with health professionals who have expertise with the BRCA+ population in Israel.